S 272 United States Senate · 119th Congress

Protect Infant Formula from Contamination Act

Summary
Protect Infant Formula from Contamination Act This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula.  Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded.  Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day.  Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action.  Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Jan 2026
Senate Passage
Apr 2026
House Passage
President
Introduced Jan 28, 2025 Last action May 4, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced in Senate Engrossed in Senate · 3 edits · Apr 28, 2026
MINOR
The Engrossed version makes several refinements to the Protect Infant Formula from Contamination Act. Most notably, it explicitly names botulism as a contaminant of concern in the supply adequacy reporting requirements, expands the progress report to account for revisions driven by recalls since the FDA's 2025 strategy report, and tightens scientific terminology around genome sequencing.
REQUIREMENT

The progress report requirement now must include any revisions to the FDA's Long-Term National Strategy recommendations as a result of infant formula recalls since the report's publication, making the report more responsive to real-world events.

SCOPE

The supply adequacy reporting section now explicitly references botulism and other contaminants when discussing contamination events, both in the context of high-frequency testing and corrective action impact. This names the specific pathogen that drove the 2022 infant formula crisis.

TECHNICAL

Changed 'whole genetic sequence' to 'whole genome sequence data' in the requirement for manufacturers to provide analytical results to the Secretary, using more precise scientific terminology.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
10
Key actions
4
Committee
3
Apr 28, 2026
Upper · Passed
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074)
upper
Apr 28, 2026
Upper · Passed
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.
upper
Jan 28, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute and an amendment to the title. Without written report.
upper
Jan 15, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
upper
Jan 28, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jan 28, 2025
Introduced
Introduced in Senate
upper
1 primary · 9 co-sponsors

Sponsors